European Union - English - EMA (European Medicines Agency)

swedish orphan biovitrum international ab - nitisinone - tyrosinemias - other alimentary tract and metabolism products, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine.alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

aloe 35mg senna leaves 33mg rhubarb roots 33mg,zedoary roots 33mg, manna 33mg theriacivenez s.opio 33mg,angelica roots 33mg

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - ramipril, quantity: 5 mg - capsule, hard - excipient ingredients: pregelatinised maize starch; propylene glycol; brilliant blue fcf; indigo carmine; butan-1-ol; quinoline yellow; allura red ac; iron oxide black; sd alcohol 45; sd alcohol 3-a; titanium dioxide; purified water; sorbitan monolaurate; erythrosine; gelatin; sodium lauryl sulfate - treatment of hypertension. data are currently not available to support the use of tryzan caps in renovascular hypertension. post myocardial infarction heart failure. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1 g/day. for reducing the risk of myocardial infarction, stroke, cardiovascular death or the need for revascularisation procedures in patients 55 years of age or more who have clinical evidence of coronary artery disease, stroke, or peripheral vascular disease. for reducing the risk of myocardial infarction, stroke, cardiovascular death or revascularisation procedures in diabetic patients 55 years or more with one or more of the following risk factors: systolic blood pressure >160 mmhg or diastolic blood pressure >90 mmhg (or on antihypertensive treatment); total cholesterol >5.2 mmol/l; hdl cholesterol <0.9 mmol/l; current smoker; known microalbuminuria; any evidence of previous vascular disease

Australia - English - Department of Health (Therapeutic Goods Administration)

herbal supplies pty ltd - actaea racemosa,aloe ferox,angelica archangelica,carlina acaulis,cinnamomum verum,commiphora myrrha,crocus sativus,curcuma zedoaria,elettaria cardamomum,fraxinus ornus,rheum officinale,senna alexandrina,valeriana officinalis -

European Union - English - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - eftrenonacog alfa - hemophilia b - vitamin k and other hemostatics, blood coagulation factors - treatment and prophylaxis of bleeding in patients with haemophilia b (congenital factor ix deficiency).

European Union - English - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - anakinra - arthritis, rheumatoid; covid-19 virus infection - immunosuppressants - rheumatoid arthritis (ra)kineret is indicated in adults for the treatment of the signs and symptoms of ra in combination with methotrexate, with an inadequate response to methotrexate alone.covid-19kineret is indicated for the treatment of coronavirus disease 2019 (covid-19) in adult patients with pneumonia requiring supplemental oxygen (low- or high-flow oxygen) who are at risk of progressing to severe respiratory failure determined by plasma concentration of soluble urokinase plasminogen activator receptor (supar) ≥ 6 ng/ml.periodic fever syndromeskineret is indicated for the treatment of the following autoinflammatory periodic fever syndromes in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above:cryopyrin-associated periodic syndromes (caps)kineret is indicated for the treatment of caps, including:neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca)muckle-wells syndrome (mws)familial cold autoinflammatory syndrome (fcas)familial mediterranean fever (fmf)kineret is indicated for the treatment of familial mediterranean fever (fmf). kineret should be given in combination with colchicine, if appropriate.still’s diseasekineret is indicated in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above for the treatment of still’s disease, including systemic juvenile idiopathic arthritis (sjia) and adult-onset still’s disease (aosd), with active systemic features of moderate to high disease activity, or in patients with continued disease activity after treatment with non-steroidal anti-inflammatory drugs (nsaids) or glucocorticoids.kineret can be given as monotherapy or in combination with other anti-inflammatory drugs and disease-modifying antirheumatic drugs (dmards).

European Union - English - EMA (European Medicines Agency)

swedish orphan biovitrum ab - collagenase clostridium histolyticum - dupuytren contracture - other drugs for disorders of the musculo-skeletal system - , the treatment of dupuytren’s contracture in adult patients with a palpable cord., the treatment of adult men with peyronie’s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.

Canada - English - Health Canada

swedish orphan biovitrum ab (publ) - anakinra - solution - 150mg - anakinra 150mg - disease-modifying antirheumatic agents

Canada - English - Health Canada

swedish orphan biovitrum ab (publ) - palifermin - powder for solution - 6.25mg - palifermin 6.25mg - cell stimulants and proliferants

United States - English - NLM (National Library of Medicine)

natumin pharma ab - camphor (synthetic) (unii: 5tjd82a1et) (camphor (synthetic) - unii:5tjd82a1et), menthol, unspecified form (unii: l7t10eip3a) (menthol, unspecified form - unii:l7t10eip3a) - camphor (synthetic) 2.8 g in 100 g - topical analgesic temporarily relieves minor pain associated with - simple backache - muscle strains - sprains - bruises condition worsens redness is present irritation develops sympotms persist for more than 7 days or clear up and occur again within a few days you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied